Congenica Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
57
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.64M
- Investors
-
21
Congenica General Information
Description
Developer of a clinical genome interpretation platform designed to identify genetic diseases in patients. The company's platform processes genomic datasets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians and researchers with personalized medicine approaches, and driving advancements in research and clinical care.
Contact Information
Website
www.congenica.comCorporate Office
- BIC, Wellcome Genome Campus
- Hinxton
- Cambridge CB10 1DR
- England, United Kingdom
Corporate Office
- BIC, Wellcome Genome Campus
- Hinxton
- Cambridge CB10 1DR
- England, United Kingdom
Congenica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 01-May-2021 | $2.64M | Completed | Generating Revenue | ||
| 11. Later Stage VC (Series C) | 09-Nov-2020 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 30-Apr-2019 | Completed | Generating Revenue | |||
| 9. Grant | 01-Sep-2018 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 01-Mar-2017 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 01-Jan-2016 | Completed | Generating Revenue | |||
| 6. Grant | 29-Sep-2015 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 01-Apr-2015 | Completed | Generating Revenue | |||
| 4. Grant | 11-Mar-2015 | $4.59M | $3.27M | Completed | Startup | |
| 3. Seed Round | 05-Dec-2014 | $2.45M | $3.27M | Completed | Startup |
Congenica Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Ordinary | ||||||||
| B Ordinary | ||||||||
| A Ordinary | ||||||||
| B Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 4,396,070 | $0.001301 | $0.65 | $0.65 | 1x | $0.65 | 7.66% | |
| A Ordinary | 2,553,500 | $0.001301 | $0.25 | $0.25 | 1x | $0.25 | 4.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Congenica Comparisons
Industry
Financing
Details
Congenica Competitors (30)
One of Congenica’s 30 competitors is PierianDx, a Private Equity-Backed company based in Creve Coeur, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PierianDx | Private Equity-Backed | Creve Coeur, MO | ||||
| Superfluid DX | Venture Capital-Backed | South San Francisco, CA | ||||
| Genalice | Formerly PE-Backed | Harderwijk, Netherlands | ||||
| Rosalind (Decision/Risk Analysis) | Venture Capital-Backed | San Diego, CA | ||||
| Fabric Genomics | Formerly VC-backed | Oakland, CA |
Congenica Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Congenica Patents
Congenica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4441742-A1 | Next generation prenatal screening | Pending | 03-Dec-2021 | ||
| GB-202117510-D0 | Next generation prenatal screening | Pending | 03-Dec-2021 | ||
| GB-2615061-A | Next generation prenatal screening | Pending | 03-Dec-2021 | ||
| GB-202013377-D0 | 3d data structure (redraft) | Inactive | 26-Aug-2020 | ||
| GB-202013386-D0 | Application of pathogenicity model and training thereof | Inactive | 26-Aug-2020 |
Congenica Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Congenica Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Downing | Infrastructure | Minority | ||
| IDO Investments | Growth/Expansion | Minority | ||
| Image Frame Investment | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Legal & General Group | Corporation | Minority |
Congenica FAQs
-
When was Congenica founded?
Congenica was founded in 2012.
-
Where is Congenica headquartered?
Congenica is headquartered in Cambridge, United Kingdom.
-
What is the size of Congenica?
Congenica has 57 total employees.
-
What industry is Congenica in?
Congenica’s primary industry is Decision/Risk Analysis.
-
Is Congenica a private or public company?
Congenica is a Private company.
-
What is Congenica’s current revenue?
The current revenue for Congenica is .
-
How much funding has Congenica raised over time?
Congenica has raised $89.8M.
-
Who are Congenica’s investors?
Downing, IDO Investments, Image Frame Investment, , and Legal & General Group are 5 of 21 investors who have invested in Congenica.
-
Who are Congenica’s competitors?
PierianDx, Superfluid DX, Genalice, Rosalind (Decision/Risk Analysis), and Fabric Genomics are some of the 30 competitors of Congenica.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
